Panangin, 158 mg+140 mg 50 pcs.
€5.00 €4.00
Pharmacological group: Potassium and magnesium drug.
ATH code: A12CX
Pharmacodynamics: The essential intracellular cations K+ and Mg++ play key roles in the function of numerous enzymes, in the formation of bonds between macromolecules and intracellular structures, and in the mechanism of muscle contractility. The intra- and extracellular ratios of potassium, calcium, sodium, and magnesium ions influence myocardial contractility. Endogenous aspartate acts as a conductor of ions: it has high affinity for cells; due to insignificant dissociation of its salts, ions in the form of complex compounds penetrate the cell. Magnesium and potassium aspartates improve myocardial metabolism. Magnesium/potassium deficiency predisposes to the development of hypertension, coronary artery atherosclerosis, arrhythmias and metabolic changes in the myocardium.
Pharmacokinetics: Absorption is high. It is excreted by the kidneys.
Indications
Tachycardia, Heart Failure
As an adjunctive agent in the treatment of chronic heart disease (heart failure, condition after myocardial infarction), heart rhythm disorders (primarily ventricular arrhythmias), in the treatment of digitalis;
Preferral therapy for magnesium/potassium deficiency in food.
Active ingredient
Potassium and magnesium asparaginate
Composition
Active ingredients:
Magnesium asparaginate 140.0 mg (in the form of magnesium asparaginate-4 H2O – 175.00 mg) and potassium asparaginate 158.0 mg (in the form of potassium asparaginate-1/2 H2O – 166.30 mg).
Auxiliary substances:
Silicon dioxide, colloidal – 2.00 mg, povidone K30 – 3.30 mg, magnesium stearate – 4.00 mg, talc – 10.00 mg, corn starch – 86.10 mg, potato starch – 3.30 mg in the core of tablets.
Shell composition:
Macrogol 6000 – 1.40 mg, titanium dioxide Color ind. 77891, E171 – 5.30 mg, butyl methacrylate, dimethylaminoethyl methacrylate and methyl methacrylate copolymer [1:2:1]
– 6.00 mg, talc – 7.30 mg.
How to take, the dosage
Consult a doctor before use.
Overly, the drug should be used after meals, because the acidic environment of the stomach reduces its effectiveness.
The usual daily dose is 1-2 tablets 3 times a day. Maximum daily dose: 3 tablets 3 times a day.
The duration of the drug and the need for repeated courses is determined by the doctor.
.
Interaction
Pharmacodynamic: combined use with potassium-saving diuretics (triamterene, spironolactone), beta-adrenoblockers, cyclosporine, heparin, angiotensin-converting enzyme inhibitors (ACE), nonsteroidal anti-inflammatory drugs increases the risk of hyperkalemia up to arrhythmia and asystole. The use of potassium preparations together with glucocorticosteroids eliminates hypokalemia caused by the latter. Under the influence of potassium, undesirable effects of cardiac glycosides are reduced. It enhances the negative dromo- and batmotropic effect of antiarrhythmic drugs. Magnesium reduces the effects of neomycin, polymyxin B, tetracycline and streptomycin. Anesthetics increase CNS suppressive effect of magnesium preparations; simultaneous use with atracuronium, decamethonium, succinyl chloride
and suxamethonium may increase neuromuscular blockade; calcitriol increases magnesium content in blood plasma, calcium preparations reduce effect of magnesium preparations.
Pharmacokinetic: binding and enveloping agents decrease absorption of the drug in the gastrointestinal tract and a three-hour interval between oral administration of Panangin® and the listed agents should be observed.
Special Instructions
Patients with diseases accompanied by hyperkalemia require special attention: regular control of the ionogram.
Influence on the ability to drive and perform work associated with increased risk of injury: does not affect the ability to drive and engage in activities requiring high concentration and rapid psychomotor reactions.
Synopsis
Round biconvex film-coated tablets, white or almost white, with a slightly shiny and uneven surface, almost odorless.
Contraindications
High sensitivity to any of the ingredients of the drug, acute and chronic renal failure, hyperkalemia, hypermagnesemia, Addison’s disease, atrioventricular block of degree I-III, cardiogenic shock (blood pressure less than 90 mm Hg), amino acid metabolism disorders, severe myasthenia gravis, hemolysis, acute metabolic acidosis, dehydration.
WARNING
Pregnancy (especially in the first trimester) and lactation.
Side effects
Nausea, vomiting, diarrhea, pancreatic discomfort or burning (in patients with anacidic gastritis or cholecystitis), atrioventricular blockade, paradoxical reaction (increased number of extrasystoles) are possible, Hyperkalemia (nausea, vomiting, diarrhea, paresthesias), hypermagnesemia (redness of face, feeling of thirst, decreased blood pressure, hyporeflexia, respiratory depression, seizures).
Overdose
Symptoms: conduction disturbances (especially with previous pathology of the cardiac conduction system).
Treatment: intravenous calcium chloride; if necessary – hemodialysis and peritoneal dialysis.
.
Similarities
Panangin, Asparkam, Potassium and Magnesium Asparaginate, Panangin Forte
Weight | 0.045 kg |
---|---|
Shelf life | 5 years. Do not use the drug after the expiration date. |
Conditions of storage | At the temperature of 15-30 ° C. Keep out of reach of children. |
Manufacturer | Gedeon Richter Rus, Russia |
Medication form | pills |
Brand | Gedeon Richter Rus |
Other forms…
Related products
Buy Panangin, 158 mg+140 mg 50 pcs. with delivery to USA, UK, Europe and over 120 other countries.